Frankfurt - Delayed Quote EUR
Ramsay Health Care Limited (RMY.F)
20.20
+0.20
+(1.00%)
At close: May 23 at 8:02:15 AM GMT+2
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
16,560,200
16,560,200
14,863,000
13,082,100
12,348,300
Cost of Revenue
3,713,400
3,713,400
3,347,700
3,107,800
3,008,700
Gross Profit
12,846,800
12,846,800
11,515,300
9,974,300
9,339,600
Operating Expense
12,013,600
12,013,600
10,961,100
9,743,700
9,164,800
Operating Income
833,200
833,200
554,200
230,600
174,800
Net Non Operating Interest Income Expense
-613,000
-613,000
-474,300
-352,800
-391,000
Other Income Expense
164,400
164,400
447,200
660,700
957,800
Pretax Income
384,600
384,600
527,100
538,500
741,600
Tax Provision
121,300
121,300
181,500
159,300
230,100
Net Income Common Stockholders
888,700
888,700
298,100
274,000
449,000
Basic EPS
3.71
3.89
1.25
1.16
1.93
Diluted EPS
3.70
3.89
1.25
1.16
1.93
Basic Average Shares
228,150
228,500
227,900
227,800
227,700
Diluted Average Shares
239,107.88
228,500
238,862.18
236,003.45
233,125.65
Net Income from Continuing & Discontinued Operation
888,700
888,700
298,100
274,000
449,000
Normalized Income
302,110
302,110
286,015.60
281,955.20
463,835
Interest Income
7,000
7,000
39,900
36,200
7,100
Interest Expense
339,500
339,500
261,200
146,800
163,900
Net Interest Income
-613,000
-613,000
-474,300
-352,800
-391,000
EBIT
724,100
724,100
788,300
685,300
905,500
EBITDA
1,806,200
1,806,200
1,777,400
1,612,900
1,804,900
Reconciled Cost of Revenue
3,713,400
3,713,400
3,347,700
3,107,800
3,008,700
Reconciled Depreciation
1,082,100
1,082,100
989,100
927,600
899,400
Net Income from Continuing Operation Net Minority Interest
270,600
270,600
278,200
274,000
449,000
Total Unusual Items Excluding Goodwill
-46,000
-46,000
-11,700
-11,300
-21,500
Total Unusual Items
-46,000
-46,000
-11,700
-11,300
-21,500
Normalized EBITDA
1,852,200
1,852,200
1,789,100
1,624,200
1,826,400
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-14,490
-14,490
-3,884.40
-3,344.80
-6,665
6/30/2021 - 5/16/2011
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade